Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 October 2024 | Story Precious Shamase and Bulelwa Moikwathai | Photo Supplied
DHET international scholarship sessions 2024
Bulelwa Moikwaikwatlhai , Assistant Director: International Office and Dr Temwa Moyo, acting Director for International Scholarships at DHET.

The University of the Free State (UFS) Qwaqwa Campus recently hosted two information sessions on international scholarships, led by the Department of Higher Education and Training (DHET). These sessions were initiated by the Office for international Affairs.

In his welcoming address during the first information session for campus heads of department, Campus Vice-Principal: Support Services, Teboho Manchu, expressed his enthusiasm for the event and its potential benefits for students and staff. He emphasised the importance of these sessions in fostering growth and development. “We are looking forward to these engagements and hope that they will benefit all of us. Please feel welcome. I would also like to thank the Office for International Affairs and all the colleagues who have been working with them to make this interaction possible.”

Dr Temwa Moyo, acting Director for International Scholarships at the DHET, gave a comprehensive presentation on Erasmus+ programmes, which provide universities with opportunities and funding to collaborate on curriculum development for new programmes, capacity building in higher education, and full scholarships for joint master’s degrees, to name a few.

“The UFS has a significant international footprint, including on the African continent. Our department’s role is to stimulate international collaboration among institutions and to strengthen national collaborations to share best practices and build networks and capacity. This is the idea of the Erasmus + programmes,” explained Dr Moyo.

The DHET representative emphasised the department’s commitment to fostering international collaboration among universities and institutions. He explained that the Erasmus+ programmes aim to empower institutions and capacitate them to engage globally.

In the second student-centred session, Prof Ralph Clark, Director of the Afromontane Research Unit, encouraged students to take advantage of these opportunities because they enhance one’s networks, perspectives, and knowledge, as well as provide a platform for students to participate in and contribute to conversations and activities aimed at addressing global challenges with societal impact. The event provided attendees with various international opportunities through the DHET to support their academic pursuits. Students and staff learned about the benefits of studying abroad, the requirements, and the application process. The DHET’s emphasis on institutional partnerships also highlights the possibility of enriching academic exchange and cultural experiences.

Overall, the DHET international scholarship sessions on the UFS Qwaqwa Campus were a resounding success, with both students and staff attending in numbers. These sessions inspired students and staff to explore the exciting possibilities of global engagements.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept